Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | Nucleoside chemotherapy for pancreatic, lung, bladder and ovarian cancers. | Platinum chemotherapy with less nerve and kidney toxicity than cisplatin. |
| Body system | Cancer | Cancer |
| Drug class | Antimetabolites | Platinum chemotherapy |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | Pancreatic cancer, Lung cancer, Ovarian cancer, Bladder and breast cancer | Ovarian cancer, Lung cancer, Head and neck cancer, Breast and other cancers |
| How it works | Blocks cancer cells from copying their DNA. | Damages cancer cell DNA so the cells die. |
| Starts working | Depends on the cancer and regimen | Depends on the cancer and regimen |
| Half-life | Minutes (gemcitabine); 8–17 hours (metabolite) | About 3–6 hours |
| Typical adult dose | Dosed by your cancer team according to the treatment protocol. | Dosed by your cancer team according to the treatment protocol. |
| Forms | IV infusion | IV infusion |
| Common side effects | Low blood counts, Nausea, Rash, Flu-like symptoms, Swollen ankles | Nausea and vomiting, Tiredness, Low blood counts, Hair thinning |
| Serious side effects | Severe low blood counts, Lung inflammation, Haemolytic uraemic syndrome (rare), Capillary leak (rare) | Severe low platelets or white cells, Allergic reactions after repeated cycles, Kidney effects |
| Don't take if | Severe kidney or liver impairment; Radiotherapy given at the same time; Pregnancy | Severe bone marrow suppression; Allergy to platinum drugs; Pregnancy |
| Alcohol | Best to limit. Alcohol can add to nausea and tiredness; ask your cancer team. | Best to limit. Alcohol can add to nausea and tiredness; ask your cancer team. |
| Pregnancy | Usually avoidedCan harm a developing baby. Effective contraception is advised during and after treatment. | Usually avoidedCan harm a developing baby. Effective contraception is advised during and after treatment. |
| Breastfeeding | Usually avoidedAvoid breastfeeding during treatment. | Usually avoidedAvoid breastfeeding during treatment. |
| In use since | — | — |
| Brand names | United States: Gemzar, InfugemUnited Kingdom: GemzarIndia: Gemcite, Gemzar | United States: Paraplatin (generic available)United Kingdom: Carboplatin (generic)India: Kemocarb, Carboplatin (generic) |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM), hospital useIndia: Schedule H |
| ATC code | L01BC05 | L01XA02 |
Taken together
- ModerateGemcitabine + Carboplatin: Added bone marrow suppression
Both can lower white cells, red cells or platelets; together the risk of infection and bleeding rises.